comparemela.com

Latest Breaking News On - Taneli jouhikainen - Page 1 : comparemela.com

EQS-Adhoc: Relief Reports Half-Year 2021 Results and Provides Corporate Update

EQS-Adhoc: Relief Reports Half-Year 2021 Results and Provides Corporate Update
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Relief Reports Half-Year 2021 Results and Provides Corporate Update

Relief Reports Half-Year 2021 Results and Provides Corporate Update
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports Half-Year 2021 Results and Provides Corporate Update

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports Half-Year 2021 Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

BioSpace Movers & Shakers, June 4

BioSpace Movers & Shakers, June 4

Published: Jun 03, 2021 By Alex Keown 180 Life Sciences Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Officer. Her most recent role was at Columbia University as Managing Director of NY Life Science Venture Fund.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.